Differentiation of neural stem cells and therapeutic use theeof
Details for Australian Patent Application No. 2002325712 (hide)
International Classifications
Event Publications
23 January 2003 Complete Application Filed
Priority application(s): 60/322,514 14.09.01 US; 60/316,365 30.08.01 US; 60/316,579 31.08.01 US; 60/386,404 07.06.02 US
5 June 2003 Application Open to Public Inspection
Published as AU-B-2002325712
19 July 2007 Application Accepted
Published as AU-B-2002325712
29 November 2007 Standard Patent Sealed
28 February 2008 Application for Amendment
The nature of the amendment is as shown in the statement(s) filed 01 Feb 2008. Address for service in Australia - Shelston IP Level 21 60 Margaret Street Sydney NSW 2000
31 July 2008 Amendment Made
The nature of the amendment is as shown in the statement(s) filed 01 Feb 2008 2003
Legal
The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.
Next and Previous Patents/Applications
2002325713-Subunit respiratory syncytial virus vaccine preparation
2002325711-Prolactin induced increase in neutral stem cell numbers and therapeutical use thereof
IP Reporting Samples
Customised IP Reporting
IP Insider for IP Professionals
IP Monitor Professional
- Editable Word format reports
- For IP Professionals
- Multiuser